Our previous study reveals that FLT3-ITD and MLL-AF9 oncogenes, which present with a high leukemic burden and confer a poor prognosis in patients with AML, contributed to the silencing of GADD45g in AML10. This evidence concerns the gene FLT3 and acute myeloid leukemia.